1. Home
  2. AMKR vs BMRN Comparison

AMKR vs BMRN Comparison

Compare AMKR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amkor Technology Inc.

AMKR

Amkor Technology Inc.

N/A

Current Price

$47.76

Market Cap

15.6B

Sector

Technology

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$66.63

Market Cap

13.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMKR
BMRN
Founded
1968
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6B
13.0B
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
AMKR
BMRN
Price
$47.76
$66.63
Analyst Decision
Buy
Buy
Analyst Count
8
18
Target Price
$64.50
$88.22
AVG Volume (30 Days)
3.8M
2.2M
Earning Date
04-27-2026
05-04-2026
Dividend Yield
0.47%
N/A
EPS Growth
4.90
N/A
EPS
0.33
0.77
Revenue
$4,052,650,000.00
$1,313,646,000.00
Revenue This Year
$13.24
$15.02
Revenue Next Year
$9.90
$12.23
P/E Ratio
$142.55
$86.55
Revenue Growth
N/A
17.62
52 Week Low
$25.52
$49.26
52 Week High
$96.68
$70.98

Technical Indicators

Market Signals
Indicator
AMKR
BMRN
Relative Strength Index (RSI) 39.35 56.83
Support Level $45.94 $58.03
Resistance Level $47.28 $70.98
Average True Range (ATR) 2.46 1.56
MACD -0.01 -0.34
Stochastic Oscillator 10.28 46.31

Price Performance

Historical Comparison
AMKR
BMRN

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: